Eric K. Nicholson

Array ( [id] => 6640050 [patent_doc_number] => 20100227350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Method of Screening Substance Useful in Treating Disease With the Use of GPR40 and Phospholipase' [patent_app_type] => utility [patent_app_number] => 12/084697 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20161 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227350.pdf [firstpage_image] =>[orig_patent_app_number] => 12084697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416332 [patent_doc_number] => 20090042219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Novel Transporter Protein in Mammal and Utilization of the Same' [patent_app_type] => utility [patent_app_number] => 12/089646 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21285 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042219.pdf [firstpage_image] =>[orig_patent_app_number] => 12089646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343278 [patent_doc_number] => 20100330066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Methods for Use with Baff Antagonists' [patent_app_type] => utility [patent_app_number] => 12/083614 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14491 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330066.pdf [firstpage_image] =>[orig_patent_app_number] => 12083614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361600 [patent_doc_number] => 20090036394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'GRP 146 Receptor' [patent_app_type] => utility [patent_app_number] => 12/088051 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18791 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036394.pdf [firstpage_image] =>[orig_patent_app_number] => 12088051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102629 [patent_doc_number] => 07723298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Cytokine receptor' [patent_app_type] => utility [patent_app_number] => 11/539780 [patent_app_country] => US [patent_app_date] => 2006-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48518 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723298.pdf [firstpage_image] =>[orig_patent_app_number] => 11539780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046012 [patent_doc_number] => 20070264685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'POLYNUCLEOTIDES ENCODING CYTOKINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/539789 [patent_app_country] => US [patent_app_date] => 2006-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48514 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264685.pdf [firstpage_image] =>[orig_patent_app_number] => 11539789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253271 [patent_doc_number] => 20070134727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'ANTIBODIES TO CYTOKINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/539816 [patent_app_country] => US [patent_app_date] => 2006-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48522 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134727.pdf [firstpage_image] =>[orig_patent_app_number] => 11539816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148787 [patent_doc_number] => 20070048847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'METHODS OF PRODUCING ANTIBODIES TO CYTOKINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/539841 [patent_app_country] => US [patent_app_date] => 2006-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48514 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048847.pdf [firstpage_image] =>[orig_patent_app_number] => 11539841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7741029 [patent_doc_number] => 08106156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'PRO1120 polypeptides' [patent_app_type] => utility [patent_app_number] => 11/538714 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 550 [patent_figures_cnt] => 550 [patent_no_of_words] => 58733 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106156.pdf [firstpage_image] =>[orig_patent_app_number] => 11538714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915652 [patent_doc_number] => 20080096252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'PRODUCTION AND PURIFICATION OF IL-29' [patent_app_type] => utility [patent_app_number] => 11/538688 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36732 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096252.pdf [firstpage_image] =>[orig_patent_app_number] => 11538688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688152 [patent_doc_number] => 20080032333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'POLYNUCLEOTIDES ENCODING SOLUBLE ZALPHA11 CYTOKINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/538735 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58130 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032333.pdf [firstpage_image] =>[orig_patent_app_number] => 11538735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098424 [patent_doc_number] => 20110003973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'ANTIBODIES TO ZALPHA11 CYTOKINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/538331 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58119 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003973.pdf [firstpage_image] =>[orig_patent_app_number] => 11538331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062479 [patent_doc_number] => 20070224118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/538350 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58105 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224118.pdf [firstpage_image] =>[orig_patent_app_number] => 11538350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5526805 [patent_doc_number] => 20090196882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'METHODS OF PRODUCING ANTIBODIES TO ZALPHA11 CYTOKINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/538319 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58099 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20090196882.pdf [firstpage_image] =>[orig_patent_app_number] => 11538319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539997 [patent_doc_number] => 20090221802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'SOLUBLE ZALPHA11 CYTOKINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/538359 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58119 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221802.pdf [firstpage_image] =>[orig_patent_app_number] => 11538359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651008 [patent_doc_number] => 20080038264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 11/537311 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 770 [patent_figures_cnt] => 770 [patent_no_of_words] => 57090 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11537311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126591 [patent_doc_number] => 20070238862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Compositions and methods comprising a ligand of ChemerinR' [patent_app_type] => utility [patent_app_number] => 11/529867 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 35268 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238862.pdf [firstpage_image] =>[orig_patent_app_number] => 11529867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085340 [patent_doc_number] => 20070275391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'NOVEL G-PROTEIN COUPLED RECEPTORS AND DNA SEQUENCES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/537424 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11654 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275391.pdf [firstpage_image] =>[orig_patent_app_number] => 11537424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259876 [patent_doc_number] => 20070213508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Compositions and methods comprising a ligand of chemerinR' [patent_app_type] => utility [patent_app_number] => 11/540001 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 35244 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213508.pdf [firstpage_image] =>[orig_patent_app_number] => 11540001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259878 [patent_doc_number] => 20070213510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Compositions and methods comprising a ligand of ChemerinR' [patent_app_type] => utility [patent_app_number] => 11/541197 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 35239 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213510.pdf [firstpage_image] =>[orig_patent_app_number] => 11541197 [rel_patent_id] =>[rel_patent_doc_number] =>)